| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss for the year | ||||||
-16,796 | -24,959 | -50,228 | ||||
Items not affecting cash and cash equivalents: | ||||||
Change in fair value of warrant liability (note 14) | ||||||
2,222 | 4,437 | -10,956 | ||||
Provision for restructuring costs (note 13) | ||||||
-3,083 | 8 | -932 | ||||
Recapture of inventory previously written off (note 7) | ||||||
-643 | 0 | 0 | ||||
Depreciation, amortization and impairment (notes 9 and 10) | ||||||
94 | 280 | 341 | ||||
Deferred income taxes (note 20) | ||||||
-3,479 | 0 | 0 | ||||
Share-based compensation costs (note 16) | ||||||
182 | 1,082 | 919 | ||||
Employee future benefits (note 18) | ||||||
246 | 382 | 351 | ||||
Amortization of deferred revenues (note 5) | ||||||
458 | 345 | 248 | ||||
Foreign exchange (gain) loss on items denominated in foreign currencies | ||||||
-553 | 87 | 1,581 | ||||
Gain on disposal of property, plant and equipment | ||||||
136 | 1 | 264 | ||||
Other non-cash items | ||||||
-19 | -83 | 154 | ||||
Gain associated with the extinguishment of warrant liability | ||||||
0 | 0 | 162 | ||||
Transaction cost allocated to warrants issued (note 16) | ||||||
0 | 56 | 2,208 | ||||
Series B Warrant exercise inducement fee (note 14) | ||||||
0 | 0 | 2,926 | ||||
Changes in operating assets and liabilities (note 19) | ||||||
2,212 | 1,064 | 3,395 | ||||
Net cash provided by operating activities of discontinued operations | ||||||
0 | 0 | 85 | ||||
Net cash used in operating activities | ||||||
-22,913 | -29,010 | -33,844 | ||||
Cash flows from financing activities | ||||||
Proceeds from issuances of common shares, warrants (including pre-funded warrants), net of cash transaction costs of $250, $1,107, and $4,223 in 2017, 2016, and 2015, respectively (note 16) | ||||||
7,788 | 9,924 | 49,427 | ||||
Proceeds from warrants exercised (note 14) | ||||||
242 | 0 | 0 | ||||
Series B Warrant exercise inducement fee (note 14) | ||||||
0 | 0 | 2,926 | ||||
Payment pursuant to warrant amendment agreements (note 16) | ||||||
0 | 0 | 5,703 | ||||
Net cash provided by financing activities | ||||||
8,030 | 9,924 | 40,798 | ||||
Cash flows from investing activities | ||||||
Purchase of property, plant and equipment (note 9) | ||||||
4 | 66 | 26 | ||||
Disposals of property, plant and equipment (note 9) | ||||||
161 | 2 | 505 | ||||
Decrease (increase) in restricted cash equivalents | ||||||
150 | -250 | 434 | ||||
Net cash provided by (used in) investing activities | ||||||
307 | -314 | 913 | ||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
357 | -51 | -1,348 | ||||
Net change in cash and cash equivalents | ||||||
-14,219 | -19,451 | 6,519 | ||||